ARKGvsBBPETF Comparison
VS
ARK Genomic Revolution ETF (ARKG) belongs to the BioTech & Genomics segment. Virtus LifeSci Biotech Products ETF (BBP) is part of the Tomorrow's Treatments segment. Both ETFs have the same top 1 sector exposures: Healthcare. ARKG is more expensive with a Total Expense Ratio (TER) of 0.75%, versus 0.34% for BBP. ARKG is up 55.33% year-to-date (YTD) with +$52M in YTD flows. BBP performs worse with 29.77% YTD performance, and +$50M in YTD flows. Run a side-by-side ETF comparison of ARKG and BBP below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
ARKG vs BBP performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/10/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | ARKG BBP | +2.26%+2.31% | +38.05%+22.34% | +55.33%+29.77% | +83.03%+48.76% | +43.84%+95.24% | -45.48%+99.54% |
| Flows | ARKG BBP | +$26M+$5M | +$132M+$20M | +$52M+$50M | +$69M+$62M | -$505M+$68M | -$2.24B+$61M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | ARKG BBP | +43.14%+26.03% | +44.21%+25.17% | +43.94%+24.72% | +46.36%+26.61% |
| Max drawdown | ARKG BBP | -13.89%-9.34% | -27.52%-9.59% | -46.41%-25.54% | -78.04%-37.61% |
| Max drawdown duration | ARKG BBP | 32d39d | 126d48d | 882d292d | 1817d586d |
Trading data
ARKG | BBP | |
Last sale 9/11/2026 at 1:30 PM | $45.56 | $103.46 |
| Previous close 09/10/2026 | $45.38 | $103.47 |
| Consolidated volume 09/10/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
ARKG
is actively managed and doesn’t replicate an indexARKG | BBP | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/11/2026 at 1:30 PM
Live
Closed
ARKG | BBP | |
|---|---|---|
| Last price | $45.56 | $103.46 |
| 1D performance | +0.40% | -0.01% |
| AuM | $1.84 B | $113.85 M |
| E/R | 0.75% | 0.34% |
Characteristics
ARKG | BBP | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Ark Investment | VIRTUS Investment Partners |
| Benchmark | - | LifeSci Biotechnology Products Index |
| N° of holdings | 31 | 66 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | April 2, 2019 | December 16, 2014 |
| ESG | No | No |
Advertisement
Exposure
Countries
ARKG
USA
88.43%
Other
11.57%
BBP
USA
86.5%
Other
13.5%
Sectors
ARKG
Healthcare
97.99%
Other
2.01%
BBP
Healthcare
98.2%
Other
1.8%
Diversification
ARKG
Total weight of top 15 holdings out of 15
75.55%
BBP
Total weight of top 15 holdings out of 15
26.78%
Top 15 holdings
Data as of July 31, 2026
ARKG
10X Genomics, Inc.
9.41%
Twist Bioscience Corp.
7.74%
Tempus AI, Inc.
6.57%
CRISPR Therapeutics AG
6.30%
Personalis, Inc.
5.48%
Absci Corp.
5.15%
Guardant Health, Inc.
4.75%
Illumina, Inc.
4.75%
Eli Lilly & Co.
4.69%
CareDx, Inc.
4.31%
Natera, Inc.
4.14%
Beam Therapeutics, Inc.
3.78%
Compass Pathways Plc
3.26%
Recursion Pharmaceuticals, Inc.
2.63%
Adaptive Biotechnologies Corp.
2.58%
BBP
Crinetics Pharmaceuticals, Inc.
3.24%
Verastem, Inc.
1.98%
Nuvation Bio, Inc.
1.80%
Omeros Corp.
1.73%
Geron Corp.
1.72%
BridgeBio Pharma, Inc.
1.68%
Agios Pharmaceuticals, Inc.
1.67%
Protagonist Therapeutics, Inc.
1.65%
BeOne Medicines Ltd.
1.64%
Kiniksa Pharmaceuticals International Plc
1.63%
Precigen, Inc.
1.62%
Xeris Biopharma Holdings, Inc.
1.61%
ACADIA Pharmaceuticals, Inc.
1.60%
Iovance Biotherapeutics, Inc.
1.60%
Rhythm Pharmaceuticals, Inc.
1.60%
Frequently asked questions about ARKG and BBP
How have the ARKG and BBP ETFs performed in 2026?
As of September 10, 2026, ARKG is up 55.33% year-to-date (YTD), while BBP has returned 29.77%. That puts ARKG better performer ahead so far this year.
Which ETF is attracting more investor money: ARKG or BBP?
Year-to-date, the ARKG ETF saw +$52M in flows, compared to +$50M for BBP.
Which ETF is more volatile: ARKG or BBP?
Over the past year, ARKG had a volatility of 44.21%, while BBP experienced 25.17%.
Which ETF is bigger: ARKG or BBP?
As of September 10, 2026, ARKG holds $1.84 B in assets under management (AUM), while BBP manages $113.85 M.
What sectors do the ARKG and BBP ETFs invest in?
ARKG leans toward sectors like Healthcare. Meanwhile, BBP focuses on Healthcare.
What are the top holdings of the ARKG ETF and BBP ETF?
ARKG top holdings include 10X Genomics, Inc., Twist Bioscience Corp. and Tempus AI, Inc.. BBP holds in its top three: Crinetics Pharmaceuticals, Inc., Verastem, Inc. and Nuvation Bio, Inc..
Which ETF is more diversified: ARKG or BBP?
ARKG holds 31 securities with 75.55% of its assets in the top 15. BBP has 66 securities and a top 15 weight of 26.78%.
Advertisement
Latest news about ARKG & BBP
Advertisement
